D Scott LaMontagne
Biographic Data
| ID | 6056045 |
|---|---|
| NAME | D Scott LaMontagne |
| GIVEN NAMES | D Scott |
| FAMILY NAME | LaMontagne |
| SIGNATURE | LAMONTAGNE D S |
| AFFILIATIONS | Program for Appropriate Technology in Health |
| ORCID | 0009-0005-8392-5790 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 5 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Evaluating the cost and operational context for national human papillomavirus (HPV) vaccine delivery in three regions of Ethiopia
Cervical cancer is the second leading cause of cancer deaths among women in Ethiopia. Human papillomavirus (HPV) vaccination is a primary prevention method for cervical cancer and was introduced in Ethiopia in 2018. We conducted a cross-sectional, mixed-methods study to understand the operational context for the HPV vaccination program and the associated costs in three regions of Ethiopia. Operations research provided insights on the frequency an…
HPV vaccination introduction worldwide and WHO and Unicef estimates of national HPV immunization coverage 2010–2019
WHO/UNICEF estimates for HPV vaccination coverage from 2010 to 2019 are analyzed against the backdrop of the 90% coverage target for HPV vaccination by 2030 set in the recently approved global strategy for cervical cancer elimination as a public health problem. As of June 2020, 107 (55%) of the 194 WHO Member States have introduced HPV vaccination. The Americas and Europe are by far the WHO regions with the most introductions, 85% and 77% of thei…
Qualitative study of the feasibility of HPV vaccine delivery to young adolescent girls in Vietnam
The learning from Vietnam has identified critical elements for successful vaccine delivery that can provide a model for other countries to consider during their planning of national rollout of HPV vaccine
Acceptance patterns and decision-making for human papillomavirus vaccination among parents in Vietnam
Vietnam's HPV vaccination experience speaks to the importance of close collaboration with the government to make the most of high levels of trust, and to reduce suspicions about new vaccines that may arise in the context of vaccine introduction in developing country settings
Human Papillomavirus Vaccine Inaccuracies
Although Maine et al. provided a comprehensive overview of the state of cervical cancer prevention today,1 their article presented some inaccuracies and tended to downplay the benefits of vaccination and magnified its challenges. For example, the authors failed to acknowledge that immunization has much less socioeconomic variation than screening does and has very little evidence of gender bias in particular. More importantly, their calculations a…
No prominent works on this page.
Acceptance patterns and decision-making for human papillomavirus vaccination among parents in Vietnam
Vietnam's HPV vaccination experience speaks to the importance of close collaboration with the government to make the most of high levels of trust, and to reduce suspicions about new vaccines that may arise in the context of vaccine introduction in developing country settings
Human Papillomavirus Vaccine Inaccuracies
Although Maine et al. provided a comprehensive overview of the state of cervical cancer prevention today,1 their article presented some inaccuracies and tended to downplay the benefits of vaccination and magnified its challenges. For example, the authors failed to acknowledge that immunization has much less socioeconomic variation than screening does and has very little evidence of gender bias in particular. More importantly, their calculations a…
Qualitative study of the feasibility of HPV vaccine delivery to young adolescent girls in Vietnam
The learning from Vietnam has identified critical elements for successful vaccine delivery that can provide a model for other countries to consider during their planning of national rollout of HPV vaccine
HPV vaccination introduction worldwide and WHO and Unicef estimates of national HPV immunization coverage 2010–2019
WHO/UNICEF estimates for HPV vaccination coverage from 2010 to 2019 are analyzed against the backdrop of the 90% coverage target for HPV vaccination by 2030 set in the recently approved global strategy for cervical cancer elimination as a public health problem. As of June 2020, 107 (55%) of the 194 WHO Member States have introduced HPV vaccination. The Americas and Europe are by far the WHO regions with the most introductions, 85% and 77% of thei…
Evaluating the cost and operational context for national human papillomavirus (HPV) vaccine delivery in three regions of Ethiopia
Cervical cancer is the second leading cause of cancer deaths among women in Ethiopia. Human papillomavirus (HPV) vaccination is a primary prevention method for cervical cancer and was introduced in Ethiopia in 2018. We conducted a cross-sectional, mixed-methods study to understand the operational context for the HPV vaccination program and the associated costs in three regions of Ethiopia. Operations research provided insights on the frequency an…
Cervical Cancer and HPV Research (5 works) · Environmental health (5 works) · Medicine (5 works) · Hepatitis B Virus Studies (4 works) · Vaccination (4 works) · Vaccine Coverage and Hesitancy (4 works) · Cancer (3 works) · Cervical cancer (3 works) · Family medicine (3 works) · Human papillomavirus (3 works)